These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2888514)
21. Cholecystokinin and neurotensin mRNAs are differentially expressed in subnuclei of the ventral tegmental area. Jayaraman A; Nishimori T; Dobner P; Uhl GR J Comp Neurol; 1990 Jun; 296(2):291-302. PubMed ID: 2358538 [TBL] [Abstract][Full Text] [Related]
22. Ultrastructural localization of neurotensin-like immunoreactivity within dense core vesicles in perikarya, but not terminals, colocalizing tyrosine hydroxylase in the rat ventral tegmental area. Bayer VE; Towle AC; Pickel VM J Comp Neurol; 1991 Sep; 311(2):179-96. PubMed ID: 1684367 [TBL] [Abstract][Full Text] [Related]
23. Substance P, neurotensin and enkephalin injections into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structures. Cador M; Rivet JM; Kelley AE; Le Moal M; Stinus L Brain Res; 1989 May; 486(2):357-63. PubMed ID: 2471575 [TBL] [Abstract][Full Text] [Related]
24. Exposure to repeated immobilization stress inhibits cocaine-induced increase in dopamine extracellular levels in the rat ventral tegmental area. Sotomayor-Zárate R; Abarca J; Araya KA; Renard GM; Andrés ME; Gysling K Pharmacol Res; 2015 Nov; 101():116-23. PubMed ID: 26318765 [TBL] [Abstract][Full Text] [Related]
25. Stress-related activation of cerebral dopaminergic systems. Dunn AJ Ann N Y Acad Sci; 1988; 537():188-205. PubMed ID: 3202543 [TBL] [Abstract][Full Text] [Related]
26. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat. Ford AP; Marsden CA Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584 [TBL] [Abstract][Full Text] [Related]
27. A 6-hydroxydopamine lesion of the mesostriatal dopamine system decreases the expression of corticotropin releasing hormone and neurotensin mRNAs in the amygdala and bed nucleus of the stria terminalis. Day HE; Vittoz NM; Oates MM; Badiani A; Watson SJ; Robinson TE; Akil H Brain Res; 2002 Aug; 945(2):151-9. PubMed ID: 12126877 [TBL] [Abstract][Full Text] [Related]
29. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. Devine DP; Leone P; Pocock D; Wise RA J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399 [TBL] [Abstract][Full Text] [Related]
30. Response to stress of mesocortico-frontal dopaminergic neurones in rats after long-term isolation. Blanc G; Hervé D; Simon H; Lisoprawski A; Glowinski J; Tassin JP Nature; 1980 Mar; 284(5753):265-7. PubMed ID: 7189015 [No Abstract] [Full Text] [Related]
31. A catecholaminergic projection from the ventral tegmental area to the diagonal band of Broca: modulation by neurotensin. Kalivas PW; Jennes L; Miller JS Brain Res; 1985 Feb; 326(2):229-38. PubMed ID: 2857589 [TBL] [Abstract][Full Text] [Related]
32. Selective enhancement of dopamine utilization in the rat prefrontal cortex by food deprivation. Carlson JN; Herrick KF; Baird JL; Glick SD Brain Res; 1987 Jan; 400(1):200-3. PubMed ID: 3815068 [TBL] [Abstract][Full Text] [Related]
33. Asymmetrical distribution of neurotensin immunoreactivity following unilateral injection of 6-hydroxydopamine in rat ventral tegmental area (VTA). Zahm DS; Johnson SN Brain Res; 1989 Apr; 483(2):301-11. PubMed ID: 2495843 [TBL] [Abstract][Full Text] [Related]
34. Endogenous enkephalin modulation of dopamine neurons in ventral tegmental area. Kalivas PW; Richardson-Carlson R Am J Physiol; 1986 Aug; 251(2 Pt 2):R243-9. PubMed ID: 3017134 [TBL] [Abstract][Full Text] [Related]
35. Mesocortical dopamine-neurotensin neurons. Possible opposite role of noradrenergic pathways on heteroregulations of dopamine (D1) and neurotensin postsynaptic receptors in the rat prefrontal cortex. Tassin JP; Trovero F; Hervé D; Blanc G; Glowinski J Ann N Y Acad Sci; 1992; 668():205-16. PubMed ID: 1334386 [No Abstract] [Full Text] [Related]
36. Interactions of thyrotropin-releasing hormone (TRH) with neurotensin and dopamine in the central nucleus of the amygdala during stress ulcer formation in rats. Henke PG; Sullivan RM; Ray A Neurosci Lett; 1988 Aug; 91(1):95-100. PubMed ID: 3140144 [TBL] [Abstract][Full Text] [Related]
37. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II. Involvement of the mesolimbic dopamine system. Kalivas PW J Pharmacol Exp Ther; 1985 Nov; 235(2):544-50. PubMed ID: 4057084 [TBL] [Abstract][Full Text] [Related]
38. Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence. Rostène W; Brouard A; Dana C; Masuo Y; Agid F; Vial M; Lhiaubet AM; Pelaprat D Ann N Y Acad Sci; 1992; 668():217-31. PubMed ID: 1361114 [No Abstract] [Full Text] [Related]
39. Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the rat. Herve D; Blanc G; Glowinski J; Tassin JP Brain Res; 1982 Apr; 237(2):510-6. PubMed ID: 6805852 [TBL] [Abstract][Full Text] [Related]
40. Neurotensin inhibits both dopamine- and GABA-mediated inhibition of ventral tegmental area dopamine neurons. Stuhrman K; Roseberry AG J Neurophysiol; 2015 Sep; 114(3):1734-45. PubMed ID: 26180119 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]